Can AI Democratize the Global Fight Against Malaria? 26/11/2025 Felix Sassmannshausen Artificial intelligence could compress years of drug discovery into months – helping to overcome growing drug resistance to existing treatments for malaria and other vector-borne diseases. But scientists in low-income countries are often left behind. Jeremy Burrows, Medicines for Malaria Venture (MMV) vice president, head of drug discovery, explains how a new open-access, AI-powered drug discovery […] Continue reading -> European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Commission Moves to Ease AI Rules as WHO Warns of Patient Risks due to Regulatory Vacuum 19/11/2025 Felix Sassmannshausen Technological advances in Artificial Intelligence applications for healthcare are quickly outpacing regulatory and ethical safeguards, creating a dangerous gap in patient safety, warns a milestone report on AI in Health Systems, published Wednesday by the World Health Organization’s European Region (WHO/EURO). Paradoxically, the WHO’s urgent call for tighter AI regulation coincided with a far-reaching European […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing 23/10/2025 Matthew Hattingh DURBAN, South Africa — A top executive at Africa’s biggest drug company shared a few home truths with the continent’s health policymakers about the obstacles to local manufacturing at the Conference on Public Health in Africa (CPHIA) 2025. Aspen Pharmacare’s Dr Stavros Nicolaou blamed regulatory bottlenecks and procurement policies for the failure of drug manufacturers […] Continue reading -> Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Drive to Include Pregnant and Breastfeeding Women and Children in Clinical Trials 17/10/2025 Kerry Cullinan The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a historic event as pregnant and breastfeeding women and babies are seldom included in clinical trials despite being more vulnerable to several illnesses. But there is growing momentum for including […] Continue reading -> Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Life Expectancy Sees Post-COVID Rebound – But Deaths Among Youths In North America and Latin America Rise 13/10/2025 Elaine Ruth Fletcher BERLIN – Global life expectancy rose again in 2023 after a decline during the COVID pandemic with overall life expectancy 20 years higher as compared to 1950. But North America and Latin America are seeing higher death rates among adolescents and young adults due to a crisis in mental health – reflected in higher rates […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> Posts navigation Older posts